GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » Market Cap
中文

AngioDynamics (AngioDynamics) Market Cap

: $241.5 Mil (As of Today)
View and export this data going back to 2004. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AngioDynamics's share price for the quarter that ended in Feb. 2024 was $5.49. AngioDynamics's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 40.4 Mil. Therefore, AngioDynamics's market cap for the quarter that ended in Feb. 2024 was $221.9 Mil.

AngioDynamics's quarterly market cap declined from Aug. 2023 ($322.9 Mil) to Nov. 2023 ($262.7 Mil) and declined from Nov. 2023 ($262.7 Mil) to Feb. 2024 ($221.9 Mil).

AngioDynamics's annual market cap declined from May. 2021 ($891.3 Mil) to May. 2022 ($768.9 Mil) and declined from May. 2022 ($768.9 Mil) to May. 2023 ($374.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AngioDynamics's Enterprise Value for Today is $198.1 Mil.


AngioDynamics Market Cap Historical Data

The historical data trend for AngioDynamics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 706.77 388.78 891.30 768.93 374.72

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 490.33 374.72 322.94 262.67 221.93

Competitive Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics Market Cap Distribution

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Market Cap distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Market Cap falls into.



AngioDynamics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

AngioDynamics's Market Cap for the fiscal year that ended in May. 2023 is calculated as

Market Cap (A: May. 2023 )=Share Price (A: May. 2023 )*Shares Outstanding (EOP) (A: May. 2023 )
=$9.46*39.6114
=$374.7

AngioDynamics's Market Cap for the quarter that ended in Feb. 2024 is calculated as

Market Cap (Q: Feb. 2024 )=Share Price (Q: Feb. 2024 )*Shares Outstanding (EOP) (Q: Feb. 2024 )
=$5.49*40.4245
=$221.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AngioDynamics  (NAS:ANGO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


AngioDynamics Market Cap Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (AngioDynamics) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Executives
Lorinda Burgess director 22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff director C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea officer: SVP/GM, VIT C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel officer: SVP Global Operations and R&D 400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini officer: SVP International C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge officer: SVP and General Counsel 14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer director, officer: President and CEO COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Wesley Johnson director
Chad Thomas Campbell officer: SVP/GM, Vascular Access 140 POKANOKET PATH, WRENTHAM MA 02093
Warren Jr Nighan officer: SVP Quality and Regulatory ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Richard C Rosenzweig officer: SVP and General Counsel C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould director 247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher officer: SVP and GM of Oncology 14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner officer: EVP and CFO C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421